NCT05124860

Brief Summary

The metabolic alterations associated with critical illness have significant implications for the nutritional management of ICU patients. Despite this, little is known about these changes in patients requiring prolonged organ support and nutritional therapy. The overall aim of this study is to describe changes in metabolism over time in a large prospective cohort of patients requiring \>10 days of ICU care. Our hypothesis is that there is a significant change in mean energy expenditure and respiratory quotient (RQ) between the early (day 1-3), intermediate (day 4-10) and late (\>10 days) phase in ICU.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
714

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2022

Typical duration for all trials

Geographic Reach
4 countries

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2021

Completed
24 days until next milestone

First Posted

Study publicly available on registry

November 18, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

February 21, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 18, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2025

Completed
Last Updated

April 11, 2025

Status Verified

April 1, 2025

Enrollment Period

2.4 years

First QC Date

October 25, 2021

Last Update Submit

April 9, 2025

Conditions

Keywords

Energy expenditureIndirect calorimetryMetabolismProlonged critical illness

Outcome Measures

Primary Outcomes (1)

  • Change in resting energy expenditure over time in patients who stay in ICU for >10 days.

    Kcal/kg adjusted body weight/24 hours.

    From date of ICU admission to the date of ICU discharge or death, whichever came first, assessed up to 24 months.

Secondary Outcomes (3)

  • Change in respiratory quotient over time in patients who stay in ICU for >10 days.

    From date of ICU admission to the date of ICU discharge or death, whichever came first, assessed up to 24 months.

  • Change in resting energy expenditure (kcal/kg/day) over time in patients who stay in ICU for ≤10 days.

    From date of ICU admission to the date of ICU discharge or death, whichever came first, assessed up to 24 months.

  • Change in respiratory quotient over time in patients who stay in ICU for ≤10 days.

    From date of ICU admission to the date of ICU discharge or death, whichever came first, assessed up to 24 months.

Other Outcomes (1)

  • Correlations between energy expenditure/respiratory quotient and markers of inflammation, protein catabolism, antecedent characteristics and outcomes.

    From date of ICU admission to the date of ICU discharge or death, whichever came first, assessed up to 24 months.

Interventions

Indirect calorimetryDIAGNOSTIC_TEST

Measurement of metabolic rate (kcal/day) by respiratory gas analysis.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult intensive care unit patients with ≥1 measurement of energy expenditure by indirect calorimetry.

You may qualify if:

  • \>/= 18 years old.
  • Admitted to the ICU of a participating study site.
  • At least one measurement of energy expenditure performed during ICU stay.

You may not qualify if:

  • Patients readmitted to the ICU of a participating study site \>72 hours after ICU discharge and already included in the study (≥1 measurement of energy expenditure performed during prior admission). If a patient is readmitted within ≤72 hours of ICU discharge this is considered a continuation of the last ICU admission for the purposes of this study.
  • Burns \>20% of body surface area.
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Royal Melbourne Hospital

Melbourne, Australia

Location

The Alfred

Melbourne, Australia

Location

Gelderse Vallei Hospital

Ede, Netherlands

Location

Karolinska University Hospital

Huddinge, Stockholm County, 14186, Sweden

Location

Universitetssjukhuset Örebro

Örebro, Sweden

Location

Capio S:t Görans Sjukhus

Stockholm, Sweden

Location

Lucerne Cantonal Hospital

Lucerne, Switzerland

Location

Related Publications (4)

  • Preiser JC, Ichai C, Orban JC, Groeneveld AB. Metabolic response to the stress of critical illness. Br J Anaesth. 2014 Dec;113(6):945-54. doi: 10.1093/bja/aeu187. Epub 2014 Jun 26.

    PMID: 24970271BACKGROUND
  • Iwashyna TJ, Hodgson CL, Pilcher D, Bailey M, van Lint A, Chavan S, Bellomo R. Timing of onset and burden of persistent critical illness in Australia and New Zealand: a retrospective, population-based, observational study. Lancet Respir Med. 2016 Jul;4(7):566-573. doi: 10.1016/S2213-2600(16)30098-4. Epub 2016 May 4.

    PMID: 27155770BACKGROUND
  • Haines RW, Zolfaghari P, Wan Y, Pearse RM, Puthucheary Z, Prowle JR. Elevated urea-to-creatinine ratio provides a biochemical signature of muscle catabolism and persistent critical illness after major trauma. Intensive Care Med. 2019 Dec;45(12):1718-1731. doi: 10.1007/s00134-019-05760-5. Epub 2019 Sep 17.

    PMID: 31531715BACKGROUND
  • Nakamura K, Ogura K, Nakano H, Naraba H, Takahashi Y, Sonoo T, Hashimoto H, Morimura N. C-reactive protein clustering to clarify persistent inflammation, immunosuppression and catabolism syndrome. Intensive Care Med. 2020 Mar;46(3):437-443. doi: 10.1007/s00134-019-05851-3. Epub 2020 Jan 9.

    PMID: 31919541BACKGROUND

Related Links

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Martin Sundström Rehal, MD PhD

    Karolinska University Hospital

    PRINCIPAL INVESTIGATOR
  • Olav Rooyackers, PhD

    Karolinska Institutet

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 25, 2021

First Posted

November 18, 2021

Study Start

February 21, 2022

Primary Completion

July 18, 2024

Study Completion

March 21, 2025

Last Updated

April 11, 2025

Record last verified: 2025-04

Locations